Green Cross aims for W615 billion sales

Published: 2009-01-16 06:57:00

Updated: 2009-01-16 06:57:00

With its completion of new GMP plant in Osan, Chungchung Province last December, Green Gross Corporation has set an ambitious goal of 615 billion won in sales this year.

“We will produce a variety number of biodrugs including blood products and vaccines to meet the ever-growing demand at home ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK